GlassScriptPhysician profile
Josiane Tossa
NPI 1013538701
$3,546.01
in general payments reported to CMS, 2019-2025
45 companies · $3,328 in 2025
The $3,328 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $27.75 · 2023: $58.12 · 2024: $32.55 · 2025: $3,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,142 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,142.32 |
| Education | $275.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $549.44 | 2025 | Talvey, Tecvayli, Darzalex |
| Novartis Pharmaceuticals Corporation | $343.95 | 2025 | |
| Beone Medicines USA, INC. | $272.66 | 2025 | Brukinsa, Tevimbra |
| Incyte Corporation | $203.99 | 2021-2025 | Monjuvi, Zynyz, Niktimvo |
| Merck Sharp & Dohme LLC | $168.50 | 2025 | Keytruda, Keytruda Qlex, Lynparza |
| Daiichi Sankyo INC. | $139.94 | 2025 | Enhertu, Datroway |
| Regeneron Healthcare Solutions, INC. | $106.92 | 2025 | Libtayo, Lynozyfic |
| Astrazeneca Pharmaceuticals LP | $101.83 | 2025 | Imfinzi, Lynparza, Calquence |
| Seagen INC. | $99.00 | 2025 | |
| Sobi, INC | $90.60 | 2025 | |
| Celgene Corporation | $87.87 | 2023-2025 | Pomalyst, Opdivo |
| Pharmaessentia USA Corporation | $87.85 | 2025 | Besremi |
| Abbvie INC. | $86.26 | 2025 | |
| Pfizer INC. | $83.53 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $83.47 | 2025 | Akeega, Erleada |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josiane Tossa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.